AU2002210926A1 - Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis - Google Patents

Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis

Info

Publication number
AU2002210926A1
AU2002210926A1 AU2002210926A AU2002210926A AU2002210926A1 AU 2002210926 A1 AU2002210926 A1 AU 2002210926A1 AU 2002210926 A AU2002210926 A AU 2002210926A AU 2002210926 A AU2002210926 A AU 2002210926A AU 2002210926 A1 AU2002210926 A1 AU 2002210926A1
Authority
AU
Australia
Prior art keywords
rheumatoid arthritis
remedies
genomes
participating
evaluating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002210926A
Other versions
AU2002210926B2 (en
Inventor
Yoshitake Konishi
Shunichi Shiozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/JP2001/009313 external-priority patent/WO2002034912A1/en
Publication of AU2002210926A1 publication Critical patent/AU2002210926A1/en
Application granted granted Critical
Publication of AU2002210926B2 publication Critical patent/AU2002210926B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002210926A 2000-10-24 2001-10-24 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis Expired AU2002210926B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2000324296 2000-10-24
JP2000-324296 2000-10-24
JP2001090546 2001-03-27
JP2001-90546 2001-03-27
JP2001-99990 2001-03-30
JP2001099990 2001-03-30
PCT/JP2001/009313 WO2002034912A1 (en) 2000-10-24 2001-10-24 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis

Publications (2)

Publication Number Publication Date
AU2002210926A1 true AU2002210926A1 (en) 2002-07-11
AU2002210926B2 AU2002210926B2 (en) 2005-12-15

Family

ID=27345019

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1092602A Pending AU1092602A (en) 2000-10-24 2001-10-24 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detectingthem and therapeutic method and remedies for rheumatoid arthritis
AU2002210926A Expired AU2002210926B2 (en) 2000-10-24 2001-10-24 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU1092602A Pending AU1092602A (en) 2000-10-24 2001-10-24 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detectingthem and therapeutic method and remedies for rheumatoid arthritis

Country Status (7)

Country Link
US (1) US7306908B2 (en)
EP (1) EP1335021A4 (en)
JP (1) JP3898126B2 (en)
KR (1) KR100944022B1 (en)
AU (2) AU1092602A (en)
CA (1) CA2426765C (en)
WO (1) WO2002034912A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4242590B2 (en) 2002-01-11 2009-03-25 俊一 塩澤 Disease susceptibility genes for rheumatoid arthritis and use thereof
ES2428321T3 (en) * 2003-08-20 2013-11-07 University Of Miami Compositions and methods to treat inflamed lung disease
JP3710809B1 (en) * 2004-02-26 2005-10-26 俊一 塩澤 Polynucleotides involved in the development of rheumatoid arthritis and uses thereof
JP2006067829A (en) * 2004-08-31 2006-03-16 Institute For Rheumatic Diseases Co Ltd POLYPEPTIDE BINDABLE TO d-DOMAIN OF DR3 GENE AND USE OF THE POLYPEPTIDE
US20070128184A1 (en) 2005-08-30 2007-06-07 Eckhard Podack Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
TWI531362B (en) 2008-07-21 2016-05-01 艾爾康股份有限公司 Ophthalmic device having therapeutic agent delivery capability
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
WO2011017303A1 (en) 2009-08-03 2011-02-10 University Of Miami Method for in vivo expansion of t regulatory cells
US8766034B2 (en) 2010-09-22 2014-07-01 Cedars-Sinai Medical Center TL1A model of inflammation fibrosis and autoimmunity
US20140193410A1 (en) 2013-01-09 2014-07-10 University Of Miami Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein
EP4285988A3 (en) 2013-03-27 2024-03-06 Cedars-Sinai Medical Center Treating fibrosis by inhibiting tl1a
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
JP6672310B2 (en) 2014-09-15 2020-03-25 アブビトロ， エルエルシー High-throughput nucleotide library sequencing
KR102464372B1 (en) 2016-03-17 2022-11-04 세다르스-신나이 메디칼 센터 Methods of diagnosing inflammatory bowel disease through rnaset2
WO2021046343A1 (en) * 2019-09-06 2021-03-11 Teleflex Medical Incorporated Lysing solution for real-time determining the identification and antibiotic resistance of pathogenic microorganisms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585464A (en) 1993-02-19 1996-12-17 Theratech, Inc. Recombinant antigen for diagnosing rheumatoid arthritis
CA2158822C (en) 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
WO1997033904A1 (en) * 1996-03-12 1997-09-18 Human Genome Sciences, Inc. Death domain containing receptors
AU730817B2 (en) 1997-05-15 2001-03-15 Shunichi Shiozawa A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis
KR100755504B1 (en) 1999-03-20 2007-09-04 시오자와 순이찌 Rheumatoid Arthritis Gene
WO2001032921A2 (en) * 1999-11-01 2001-05-10 Shunichi Shiozawa Method of diagnosing rheumatoid arthritis

Similar Documents

Publication Publication Date Title
AU2002210926A1 (en) Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
EP1335021A4 (en) Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
AU2003261073A8 (en) Combined diagnostic and therapeutic ultrasound system
EP1581119A4 (en) Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
AU2003251988A1 (en) Method and system for using ultrasound in cardiac diagnosis and therapy
AU2003282373A1 (en) Methods device and system for in vivo diagnosis
WO2003034984A9 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
IL213564B (en) Anti-vla-1 antibody, in vitro method of determining the level of vla-1 in a tissue, a composition comprising the anti-vla-1 antibody and therapeutic and diagnostic uses thereof
AU3329501A (en) Method and apparatus combining diagnostic ultrasound with therapeutic ultrasoundto enhance thrombolysis
AU2002353695A1 (en) Disposable apparatus for use in blood testing
AU2003298703A1 (en) Diagnostic tests and methods for diagnosing inflammatory bowel disease
WO2002093173A3 (en) Screening method using pim1-kinase or pim3-kinase
EP1677677A4 (en) Contrast media for use in medical and diagnostic procedures and methods of using the same
WO2003000733A3 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
AU2002364808A1 (en) Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses
AU2003223033A8 (en) System for point of care diagnosis and/or analysis
EP1539957A4 (en) Novel diagnostic and therapeutic methods and reagents therefor
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
AU7922300A (en) Diagnosis kit, method and microarray for determining human detoxification capacity
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
AU3153100A (en) Gas analyser and the use thereof in medical diagnostics
WO2002018633A3 (en) Determination of the ability of patients to respond to tumour treatment
AU2001285026A1 (en) Methods and compositions for use in the diagnosis and treatment of chronic immune disease
WO2001089548A3 (en) Pharmaceutical use of fibulin-1